XBiotech Stock (NASDAQ:XBIT), Quotes and News Summary

Q: What sector and industry does XBiotech (XBIT) operate in?

XBiotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XBiotech Stock (NASDAQ: XBIT) stock price, news, charts, stock research, profile.

Open	$7.640
Close	$8.040
Volume / Avg.	76.250K / 67.769K
Day Range	7.500 - 8.340
52 Wk Range	3.050 - 9.960
Market Cap	$266.141M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	2.99%
Days to Cover	7.46

Recent News

Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers

Lisa Levin

Dow Jumps Over 100 Points; US Housing Starts Rise In April

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.37% to 33,135.37 while the NASDAQ rose 0.39% to 12,391.68. The S&P 500, also rose, gaining, 0.45% to 4,128.33.

Lisa Levin

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About XBiotech Inc

Sector

Health Care

Industry

Biotechnology

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in dis...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy XBiotech (XBIT) stock?

You can purchase shares of XBiotech (NASDAQ: XBIT) through any online brokerage.

View our list of the best stock brokerages.

Who are XBiotech's (XBIT) competitors?

Other companies in XBiotech’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT) and RAPT Therapeutics (NASDAQ:RAPT).

What is the target price for XBiotech (XBIT) stock?

The latest price target for XBiotech (NASDAQ: XBIT) was reported by Piper Sandler on Tuesday, April 7, 2020. The analyst firm set a price target for 18.00 expecting XBIT to rise to within 12 months (a possible 105.95% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for XBiotech (XBIT)?

The stock price for XBiotech (NASDAQ: XBIT) is $8.74 last updated April 17, 2024 at 1:54 AM EDT.

Does XBiotech (XBIT) pay a dividend?

There are no upcoming dividends for XBiotech.

When is XBiotech (NASDAQ:XBIT) reporting earnings?

XBiotech’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is XBiotech (XBIT) going to split?

There is no upcoming split for XBiotech.

What sector and industry does XBiotech (XBIT) operate in?

XBiotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-